Published in Hepatogastroenterology on March 01, 2007
Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study. World J Surg (2013) 2.12
Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer (2010) 1.07
Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol (2014) 0.85
Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus. J Exp Clin Cancer Res (2010) 0.84
Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition. Oncotarget (2016) 0.84
Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis. Medicine (Baltimore) (2016) 0.81
Metastasis: an early event in cancer progression. J Cancer Res Clin Oncol (2016) 0.81
Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival. Biomed Res Int (2015) 0.80
Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget (2016) 0.79
Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma. PLoS One (2015) 0.78
14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α. Oncotarget (2016) 0.78
Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study. Br J Cancer (2014) 0.78
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma. J Cancer Res Clin Oncol (2016) 0.77
Portal vein tumor thrombus in advanced hepatocellular carcinoma: A case report. Oncol Lett (2015) 0.76
Hepatocellular carcinoma with main portal vein tumor thrombus: a comparative study comparing hepatectomy with or without neoadjuvant radiotherapy. HPB (Oxford) (2016) 0.76
The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. HPB (Oxford) (2015) 0.76
Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein. World J Gastroenterol (2016) 0.75
Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum. Chin J Cancer Res (2014) 0.75
Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma. Cancer Biol Med (2016) 0.75
Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus. Onco Targets Ther (2016) 0.75
New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75
A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75
High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat (2003) 1.21
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg (2014) 1.11
Alterations in the cortical thickness and the amplitude of low-frequency fluctuation in patients with post-traumatic stress disorder. Brain Res (2012) 1.04
Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbecks Arch Surg (2009) 0.97
Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS One (2012) 0.89
Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection. Hepatogastroenterology (2006) 0.89
An unusual gallbladder carcinoma with tumor thrombus in the common bile duct. J Cancer Res Ther (2013) 0.88
Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine (2010) 0.88
Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy. Oncologist (2012) 0.86
Management of retrohepatic inferior vena cava injury during hepatectomy for neoplasms. World J Surg (2003) 0.86
The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer. BMC Cancer (2014) 0.81
L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide. Antimicrob Agents Chemother (2012) 0.80
Molecular mechanics force field-based map for peptide amide-I mode in solution and its application to alanine di- and tripeptides. Phys Chem Chem Phys (2009) 0.80
Unpolarized release of vaccinia virus and HIV antigen by colchicine treatment enhances intranasal HIV antigen expression and mucosal humoral responses. PLoS One (2011) 0.80
Combination transcatheter hepatic arterial chemoembolization with thymosin alpha1 on recurrence prevention of hepatocellular carcinoma. Hepatogastroenterology (2004) 0.78
In vitro comparison of three rifampicin loading methods in a reinforced porous β-tricalcium phosphate scaffold. J Mater Sci Mater Med (2015) 0.76
Monoclonal antibody that blocks the Toll-like receptor 5 binding region of flagellin. Hybridoma (Larchmt) (2012) 0.76
[Comparison of the models of mixed liquid samples under different near-infrared spectral resolutions]. Guang Pu Xue Yu Guang Pu Fen Xi (2009) 0.75
[Determination of trace element silver in animal serum, tissues and organs by microwave digestion-ICP-MS]. Guang Pu Xue Yu Guang Pu Fen Xi (2014) 0.75